tadalafil has been researched along with u 62840 in 11 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (u 62840) | Trials (u 62840) | Recent Studies (post-2010) (u 62840) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 447 | 79 | 297 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Bowles, EA; Ellsworth, ML; Elrick, MM; Knebel, SM; Sprague, RS; Stephenson, AH; Zdanovec, AK | 1 |
| Izzo, A; Khatwa, U; Kothare, SV; Kulik, T; McSweeney, J | 1 |
| Baloira Villar, A; Núñez Fernández, M; Pousada Fernández, G; Valverde Pérez, D | 1 |
| Bowles, EA; Ellsworth, ML; Moody, GN; Sprague, RS; Stephenson, AH; Yeragunta, Y | 1 |
| Hatano, M; Imamura, T; Inaba, T; Kinugawa, K; Ko, T; Komuro, I; Maki, H; Minatsuki, S; Muraoka, H; Nitta, D; Yao, A | 1 |
| Cleveland, JM; Minai, OA; Rao, Y; Rose, JA; Tonelli, AR | 1 |
| Akerström, F; Berenguel Senén, A; Escribano Subías, P; Lázaro Salvador, M; Martinez Mateo, V; Rodriguez Padial, L | 1 |
| Argiento, P; Badagliacca, R; D'Alto, M; Farro, A; Golino, P; Naeije, R; Papa, S; Romeo, E; Russo, MG; Sarubbi, B; Vizza, CD | 1 |
| Locatelli, I; Petrovič, M | 1 |
| Kam, CW; Ruiz, FE | 1 |
| Heresi, GA; Rao, Y | 1 |
3 review(s) available for tadalafil and u 62840
| Article | Year |
|---|---|
"Nocturnal seizures" in idiopathic pulmonary arterial hypertension.
Topics: Carbolines; Cardiac Output, Low; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Oxygen Inhalation Therapy; Parasomnias; Seizures; Severity of Illness Index; Sleep Apnea Syndromes; Tadalafil; Treatment Outcome; Warfarin | 2013 |
Comparative effectiveness of pulmonary arterial hypertension drugs in treatment-naive patients: a network meta-analysis.
Topics: Antihypertensive Agents; Bayes Theorem; Comparative Effectiveness Research; Drug Combinations; Drug Therapy, Combination; Epoprostenol; Humans; Male; Network Meta-Analysis; Phenylpropionates; Pulmonary Arterial Hypertension; Pyridazines; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome; Walk Test | 2020 |
Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children.
Topics: Adolescent; Adult; Bosentan; Calcium Channel Blockers; Child; Child, Preschool; Epoprostenol; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Iloprost; Infant; Infant, Newborn; Phenotype; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Prognosis; Pulmonary Arterial Hypertension; Pyridazines; Pyrimidines; Receptors, Endothelin; Sildenafil Citrate; Sulfonamides; Tadalafil; Young Adult | 2021 |
1 trial(s) available for tadalafil and u 62840
| Article | Year |
|---|---|
Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial Hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Epoprostenol; Female; Follow-Up Studies; Functional Status; Humans; Male; Middle Aged; Pulmonary Arterial Hypertension; Survival Rate; Tadalafil; Vasodilator Agents; Walk Test | 2020 |
7 other study(ies) available for tadalafil and u 62840
| Article | Year |
|---|---|
Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytes.
Topics: Adenosine Triphosphate; Adult; Carbolines; Cyclic AMP; Epoprostenol; Erythrocytes; Female; Humans; Iloprost; Male; Middle Aged; Phosphodiesterase Inhibitors; Purinones; Signal Transduction; Tadalafil; Vasodilator Agents | 2013 |
Clinical and molecular study of 4 cases of pulmonary hypertension associated with sarcoidosis.
Topics: Bone Morphogenetic Protein Receptors, Type II; Bosentan; Disease Progression; Epoprostenol; Fatal Outcome; Female; Humans; Hypertension, Pulmonary; Kv1.5 Potassium Channel; Male; Middle Aged; Mutation; Phenylpropionates; Point Mutation; Pyridazines; Respiratory Function Tests; RNA, Messenger; Sarcoidosis; Sildenafil Citrate; Sulfonamides; Tadalafil; Treatment Outcome | 2015 |
Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertension.
Topics: Adenosine Triphosphate; Adolescent; Adult; Aged; Antihypertensive Agents; Carbolines; Cyclic AMP; Drug Synergism; Epoprostenol; Erythrocytes; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Purinones; Tadalafil; Young Adult | 2015 |
A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation.
Topics: Antihypertensive Agents; Arterial Pressure; Drug Therapy, Combination; Epoprostenol; Humans; Hypertension, Pulmonary; Immunologic Factors; Interferon-alpha; Liver Transplantation; Living Donors; Male; Middle Aged; Pulmonary Artery; Tadalafil; Treatment Outcome | 2016 |
Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.
Topics: Age Factors; Aged; Antihypertensive Agents; Connective Tissue Diseases; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Multivariate Analysis; Phenotype; Pulmonary Wedge Pressure; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome; Vasodilator Agents; Walk Test | 2016 |
Living With Severe Pulmonary Arterial Hypertension Without an Infusion Pump? Selexipag has a Role to Play.
Topics: Acetamides; Antihypertensive Agents; Drug Substitution; Drug Therapy, Combination; Epoprostenol; Female; Humans; Infusion Pumps; Middle Aged; Phenylpropionates; Pulmonary Arterial Hypertension; Pyrazines; Pyridazines; Sildenafil Citrate; Tadalafil; Vasodilator Agents | 2019 |
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
Topics: Adult; Antihypertensive Agents; Atrial Remodeling; Cardiac Catheterization; Drug Therapy, Combination; Echocardiography; Epoprostenol; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenylpropionates; Pulmonary Arterial Hypertension; Pyridazines; Retrospective Studies; Risk Reduction Behavior; Tadalafil; Treatment Outcome; Vascular Resistance; Vasodilator Agents; Ventricular Function, Right; Ventricular Remodeling; Walk Test | 2020 |